G
Gennaro Sardella
Researcher at Policlinico Umberto I
Publications - 258
Citations - 10174
Gennaro Sardella is an academic researcher from Policlinico Umberto I. The author has contributed to research in topics: Percutaneous coronary intervention & Conventional PCI. The author has an hindex of 38, co-authored 231 publications receiving 8230 citations. Previous affiliations of Gennaro Sardella include Catholic University of the Sacred Heart & Sapienza University of Rome.
Papers
More filters
Journal ArticleDOI
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial
Marco Valgimigli,Andrea Gagnor,Paolo Calabrò,Enrico Frigoli,Sergio Leonardi,Tiziana Zaro,Paolo Rubartelli,Carlo Briguori,Giuseppe Andò,Alessandra Repetto,Ugo Limbruno,Bernardo Cortese,Paolo Sganzerla,Alessandro Lupi,Mario Galli,Salvatore Colangelo,Salvatore Ierna,Arturo Ausiello,Patrizia Presbitero,Gennaro Sardella,Ferdinando Varbella,Giovanni Esposito,Andrea Santarelli,Simone Tresoldi,Marco Stefano Nazzaro,Antonio Zingarelli,Nicoletta De Cesare,Stefano Rigattieri,Paolo Tosi,Cataldo Palmieri,Salvatore Brugaletta,Sunil V. Rao,Dik Heg,Martina Rothenbühler,Pascal Vranckx,Peter Jüni +35 more
TL;DR: In patients with acute coronary syndrome undergoing invasive management, radial as compared with femoral access reduces net adverse clinical events, through a reduction in major bleeding and all-cause mortality.
Journal ArticleDOI
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis
Tullio Palmerini,Giuseppe Biondi-Zoccai,Diego Della Riva,Christoph Stettler,Diego Sangiorgi,Fabrizio D'Ascenzo,Takeshi Kimura,Carlo Briguori,Manel Sabaté,Hyo-Soo Kim,Antoinette de Waha,Elvin Kedhi,Pieter C. Smits,Christoph Kaiser,Gennaro Sardella,Antonino G.M. Marullo,Ajay J. Kirtane,Martin B. Leon,Gregg W. Stone +18 more
TL;DR: In randomised studies completed to date, CoCr-EES has the lowest rate of stent thrombosis within 2 years of implantation and if confirmed in future randomised trials, represents a paradigm shift.
Journal ArticleDOI
Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy.
Ovidio De Filippo,Fabrizio D'Ascenzo,Filippo Angelini,Pier Paolo Bocchino,Federico Conrotto,Andrea Saglietto,Gioel Gabrio Secco,Gianluca Campo,Guglielmo Gallone,Roberto Verardi,Luca Gaido,Mario Iannaccone,Marcello Galvani,Fabrizio Ugo,Umberto Barbero,Vincenzo Infantino,Luca Olivotti,Marco G. Mennuni,Sebastiano Gili,Fabio Infusino,Matteo Vercellino,Ottavio Zucchetti,Gianni Casella,Massimo Giammaria,Giacomo Boccuzzi,Paolo Tolomeo,Baldassarre Doronzo,Gaetano Senatore,Walter Grosso Marra,Andrea Rognoni,Daniela Trabattoni,Luca Franchin,Andrea Borin,Francesco Bruno,Alessandro Galluzzo,Alfonso Gambino,Annamaria Nicolino,Alessandra Truffa Giachet,Gennaro Sardella,Francesco Fedele,Silvia Monticone,Antonio Montefusco,Pierluigi Omedè,Mauro Pennone,Giuseppe Patti,Massimo Mancone,Gaetano M. De Ferrari +46 more
TL;DR: During the Covid-19 outbreak in northern Italy, the daily rate of admissions for acute coronary syndrome at 15 hospitals was significantly lower than in previous outbreaks.
Journal ArticleDOI
Ticagrelor with or without Aspirin in High-Risk Patients after PCI
Roxana Mehran,Usman Baber,Samin K Sharma,David J. Cohen,Dominick J. Angiolillo,Carlo Briguori,Jin Y Cha,Timothy Collier,George Dangas,Dariusz Dudek,Vladimír Džavík,Javier Escaned,Robert J. Gil,Paul A. Gurbel,Christian W Hamm,Timothy D. Henry,Kurt Huber,Adnan Kastrati,Upendra Kaul,Ran Kornowski,Mitchell W. Krucoff,Vijay Kunadian,Steven O. Marx,Shamir R. Mehta,David J. Moliterno,E. Magnus Ohman,Keith G. Oldroyd,Gennaro Sardella,Samantha Sartori,Richard Shlofmitz,P. Gabriel Steg,Giora Weisz,Bernhard Witzenbichler,Yaling Han,Stuart J. Pocock,C. Michael Gibson +35 more
TL;DR: Among high-risk patients who underwent PCI and completed 3 months of dual antiplatelet therapy, ticagrelor monotherapy was associated with a lower incidence of clinically relevant bleeding than ticagerelor plus aspirin, with no higher risk of death, myocardial infarction, or stroke.
Journal ArticleDOI
Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.
Giuseppe Patti,Vincenzo Pasceri,Giuseppe Colonna,Marco Miglionico,Dionigi Fischetti,Gennaro Sardella,Antonio Montinaro,Germano Di Sciascio +7 more
TL;DR: The ARMYDA-ACS trial indicates that even short-term pretreatment with atorvastatin may improve outcomes in patients with ACS undergoing early invasive strategy, and may support routine use of high-dose statins before intervention in Patients with ACS.